Your browser doesn't support javascript.
loading
Association between treatment center experience and survival after diagnosis of stage I to III Merkel cell carcinoma treated with surgery with or without postoperative radiation therapy.
Chipidza, Fallon E; Thakuria, Manisha; Schoenfeld, Jonathan D; Silk, Ann W; Catalano, Paul J; Yoon, Charles H; Hanna, Glenn J; DeCaprio, James A; Tishler, Roy B; Margalit, Danielle N.
Afiliação
  • Chipidza FE; Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts; Department of Radiation Oncology, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Thakuria M; Merkel Cell Carcinoma Center of Excellence, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Dermatology, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Schoenfeld JD; Department of Radiation Oncology, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts; Merkel Cell Carcinoma Center of Excellence, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Silk AW; Merkel Cell Carcinoma Center of Excellence, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Catalano PJ; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Yoon CH; Merkel Cell Carcinoma Center of Excellence, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts; Division of Surgical Oncology, Department of Surgery, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Hanna GJ; Merkel Cell Carcinoma Center of Excellence, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • DeCaprio JA; Merkel Cell Carcinoma Center of Excellence, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Tishler RB; Department of Radiation Oncology, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts; Merkel Cell Carcinoma Center of Excellence, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Margalit DN; Department of Radiation Oncology, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts; Merkel Cell Carcinoma Center of Excellence, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address: danielle_margalit@dfci.harvard.edu
J Am Acad Dermatol ; 84(3): 875-877, 2021 Mar.
Article em En | MEDLINE | ID: mdl-33171164
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma de Célula de Merkel / Procedimentos Cirúrgicos Dermatológicos Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma de Célula de Merkel / Procedimentos Cirúrgicos Dermatológicos Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article